EP08.01-061. A Pilot Study of Avelumab and SABR in Non-Responding and Progressing NSCLC Patients Previously Treated with a Checkpoint Inhibitor
Back to course
Pdf Summary
Asset Subtitle
Megan Eileen Daly
Meta Tag
Speaker Megan Eileen Daly
Topic Metastatic Non-small Cell Lung Cancer - Immunotherapy
Keywords
pilot study
avelumab
SABR
NSCLC
immune checkpoint inhibitors
ORR
PFS
partial response
combination therapy
trial closure
Powered By